# Vedana Therapeutics

> Canaan Partners led a Series A for Vedana Therapeutics, extending the firm’s healthcare franchise as it deploys its $850M Fund XIII.

## Why it is interesting

Vedana reflects Canaan Partners' long-standing healthcare practice (Day One Biopharmaceuticals, IDEAYA, Synthekine) alongside its technology investing, all from the same multi-generation platform. Canaan Partners led a Series A for Vedana Therapeutics, extending the firm’s healthcare franchise as it deploys its $850M Fund XIII.

## Profile

- **Stage:** series-a
- **Status:** private
- **Industries:** biotech-life-sciences
- **Coverage:** full
- **Last updated:** 2026-06-16

## Key facts

- Disclosed financing: $850M (Series A)
- Covered in 1 Venture Capital Tracker article(s)

## Investors in our directory

- https://venturecapitaltracker.com/fund/canaan-partners

## Related articles

- https://venturecapitaltracker.com/2026-canaan-partners-vedana-therapeutics-series-a

---
Source: https://venturecapitaltracker.com/startup/vedana-therapeutics